Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese Study
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.70517 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Nobuhiro Oda und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Allergy, Kameda Medical Center, Chiba, Japan. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Temporal Arteries, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aims to elucidate the diagnostic process of giant cell arteritis (GCA) by subtype in Japan.
Methods
This was a secondary analysis of a multicenter retrospective study of patients with GCA treated with tocilizumab. Patients were included in the cohort if a clinical diagnosis of GCA was made by a board‐certified rheumatologist. Cranial GCA (C‐GCA) was defined as a positive temporal artery biopsy (TAB), temporal artery ultrasound (TAU), or the presence of cranial manifestations. Large vessel GCA (LV‐GCA) was defined by a positive computed tomography (CT), positron emission tomography (PET)‐CT, or limb claudication attributable to GCA. We evaluated the diagnostic performance of each examination and assessed concordance between TAU and TAB. The diagnostic process was illustrated using flowcharts.
Results
We identified 61 GCA patients, with a median age of 74 years; 40 were female. Among C‐GCA patients, the positivity rates were 52.6% (20/38) for TAU, 70% (7/10) for magnetic resonance imaging (MRI), and 81.8% (36/44) for TAB. The positivity rates in LV‐GCA were 81.5% (22/27) for CT and 100% (16/16) for PET‐CT. Concordance between TAU and TAB varied considerably across institutions. The diagnostic workflow showed that patients with C‐GCA typically underwent multiple diagnostic examinations, and most (83.3%) TAU‐negative patients with C‐GCA had either a positive head MRI or TAB.
Conclusion
This multicenter Japanese study demonstrated the low sensitivity of TAU for cranial GCA, with performance varying across institutions. Combining head MRI and TAB with TAU may improve the diagnosis of GCA in Japanese clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Rheumatology and Allergy, Kameda Medical Center, Chiba, Japan.
- Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Emergency and General Medicine, Kyorin University, Tokyo, Japan.
- Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan.
- Department of Rheumatology, Chubu Rosai Hospital, Nagoya, Aichi, Japan.
- Department of Rheumatology, Daido Hospital, Nagoya, Aichi, Japan.
ORCID-Profile: Nobuhiro Oda, Sho Fukui, Fumika N Nagase, Takanori Ito, Hajime Inokuchi, Toshihiro Yamaguchi, Mitsuru Watanabe, Masei Suda, Naoho Takizawa, Yoichiro Haji, Yasuhiro Suyama, Eishi Uechi, Ryo Rokutanda, Hiromichi Tamaki
Zitieren
APA
Oda, N., Fukui, S., Nagase, F. N., Ito, T., Inokuchi, H., Yamaguchi, T., Watanabe, M., Suda, M., Takizawa, N., Haji, Y., Suyama, Y., Nomura, A., Uechi, E., Rokutanda, R., & Tamaki, H. (2025). Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese Study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70517
Vancouver
Oda N, Fukui S, Nagase FN, Ito T, Inokuchi H, Yamaguchi T, et al. Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese Study. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70517
BibTeX
@article{Oda2025,
author = {Oda, Nobuhiro and Fukui, Sho and Nagase, Fumika N and Ito, Takanori and Inokuchi, Hajime and Yamaguchi, Toshihiro and Watanabe, Mitsuru and Suda, Masei and Takizawa, Naoho and Haji, Yoichiro and Suyama, Yasuhiro and Nomura, Atsushi and Uechi, Eishi and Rokutanda, Ryo and Tamaki, Hiromichi},
title = {Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese Study},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.70517}
}
EUVIMED